Unique microbial signature identified in systemic sclerosis
11 June 2015 | By Victoria White
The results of a study presented at EULAR 2015 showed that people with systemic sclerosis have a unique bacterial signature in their colon.
List view / Grid view
News
TLR4 has opposing roles in breast cancer development
11 June 2015 | By Victoria White
Countering previously held beliefs, researchers have discovered that inhibiting TLR4 may not be a wise treatment strategy in all cancers...
Discovery of cellular mechanism of action of tACPA in rheumatoid arthritis
11 June 2015 | By Victoria White
ModiQuest has discovered the cellular mechanism of action of its tACPA for the treatment of rheumatoid arthritis (RA) and other diseases...
FDA awards Isarna orphan drug designation for ISTH0036 to improve glaucoma treatment outcome
10 June 2015 | By Victoria White
Isarna Therapeutics has announced that the Food and Drug Administration (FDA) has granted orphan drug designation for ISTH0036...
Selecta Biosciences initiates Phase 1 clinical study of SEL-212 in gout
10 June 2015 | By Victoria White
Selecta Biosciences has initiated a Phase 1 study to assess the safety, pharmacodynamic profile, and immunogenicity of pegsiticase, a component of SEL-212...
Polar distribution of microRNAs discovered within eukaryotic cells
10 June 2015 | By Victoria White
Researchers have discovered that certain microRNAs are also asymmetrically distributed within cells and may contribute as cell fate determinants...
Discovery gives hope for finding a treatment for amyotrophic lateral sclerosis
10 June 2015 | By Victoria White
A previously unknown link between the immune system and the death of motor neurons in amyotrophic lateral sclerosis has been discovered by scientists...
MRC Technology and Peptinnovate collaborate on therapeutics for bone diseases
10 June 2015 | By Victoria White
MRC Technology and Peptinnovate are collaborating to assess the therapeutic potential in bone diseases of peptides derived from Mycobacterium tuberculosis...
Lycera and Celgene collaborate to advance novel immune modulators
10 June 2015 | By Victoria White
Lycera has formed of an exclusive global collaboration with Celgene to take forward Lycera's proprietary pipeline for cancer and immune-mediated diseases...
Researchers discover how C. difficile toxins enter the interiors of cells
9 June 2015 | By Victoria White
Researchers have identified the molecular docking site that is responsible for C. difficile toxins being able to bind to a receptor...
Protein from Vibrio vulnificus can inhibit tumour cell growth by cutting the protein Ras
9 June 2015 | By Victoria White
Scientists have discovered that a toxin secreted by Vibrio vulnificus has potential to prevent the growth of tumours by cutting the protein Ras...
Tillots and Numab to collaborate to develop inflammatory bowel disease treatments
9 June 2015 | By
Tillotts Pharma and Numab are to collaborate to develop and commercialise new antibody-based therapies for people with inflammatory bowel disease...
FDA Grants Orphan Status for ATX-F8-117 for the treatment of haemophilia A patients in the US
9 June 2015 | By Victoria White
Apitope’s product candidate ATX-F8-117 has been granted Orphan Drug Status by the FDA for the treatment of patients with haemophilia A in the US...
Calcineurin inhibitor-based medications may protect against Alzheimer’s disease
9 June 2015 | By Victoria White
A new study has revealed that calcineurin inhibitor-based medications, such as Tacrolimus or cyclosporine, may also protect against Alzheimer’s disease...
FDA and EMA grants orphan drug designation to recAP for the treatment of hypophosphatasia
9 June 2015 | By Victoria White
AM‐Pharma has announced that the FDA and EMA have both granted orphan designation status to recAP for the treatment of hypophosphatasia...